AstraZeneca PLCAstraZeneca PLC - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The page contains a zero-cost Sustainability analysis covering AstraZeneca PLC. If you work at AstraZeneca PLC and you wish to licence your Sustainability aseessment, please get in touch. This page contains a Q&A section for AstraZeneca PLC.

AstraZeneca PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 6.9 and governance score of 8.0.

SDG Transparency Score for AstraZeneca PLC 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for AstraZeneca PLC 
8.0

Environmental

6.9

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55AstraZeneca PLC
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does AstraZeneca PLC have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose current and historical energy intensity?

LockedSign up for free to unlock

Does AstraZeneca PLC report the average age of the workforce?

LockedSign up for free to unlock

Does AstraZeneca PLC reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose cybersecurity risks?

LockedSign up for free to unlock

Does AstraZeneca PLC offer flexible work?

LockedSign up for free to unlock

Does AstraZeneca PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does AstraZeneca PLC conduct supply chain audits?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does AstraZeneca PLC conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose water use targets?

LockedSign up for free to unlock

Does AstraZeneca PLC have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did AstraZeneca PLC have a product recall in the last two years?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose incidents of discrimination?

LockedSign up for free to unlock

Does AstraZeneca PLC allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has AstraZeneca PLC issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose parental leave metrics?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does AstraZeneca PLC support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does AstraZeneca PLC reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is AstraZeneca PLC involved in embryonic stem cell research?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose its waste policy?

LockedSign up for free to unlock

Does AstraZeneca PLC report according to TCFD requirements?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose energy use targets?

LockedSign up for free to unlock

Does AstraZeneca PLC disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does AstraZeneca PLC have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for AstraZeneca PLC
These potential risks are based on the size, segment and geographies of the company.

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Sorry!

Failed to process!